FDBusiness.com

Meiogenix, Lesaffre partner on yeast

 Breaking News
  • Lactalis Expands in Infant Nutrition With €740 Million Acquisition Lactalis Group, the international dairy group based in Laval, France, is acquiring the Nutritional business of Aspen Pharmacare for €739.8 million (R12.9 billion). The business being acquired supplies a wide range of infant nutritional and growing-up milk products across both the premium and value segments. It manufactures and markets well established quality brands, including S-26, [...]...
  • Thatchers Cider to Invest £14 Million in New Cider Mill Thatchers Cider, the family owned English cider producer, is to invest £14 million in a new cider mill at its Myrtle Farm site in Somerset to meet growing demand for its products. The company has applied for planning permission and, if granted, the new mill would come on stream in 2019. “This investment is about our [...]...
  • Coca-Cola Great Britain Teams Up With Premier League Premier League and Coca-Cola Great Britain have announced a new three-and-a-half-year partnership, starting in January 2019. It is the first sponsorship Coca-Cola Great Britain will activate across multiple brands within its portfolio, showcasing a range of drinks including sparkling soft drinks, water and fruit-based drinks, with low and no-sugar options. The partnership will see Coca-Cola work [...]...
  • Barry Callebaut Completes $30 Million Capacity Expansion in North America Barry Callebaut, the world’s leading manufacturer of high-quality chocolate and cocoa products, has announced the completion of several expansion investments in three of its North American facilities located in St Hyacinthe, Quebec; Chatham, Ontario; and St Albans, Vermont. The investments amount to close to US$30 million and are in line with previously announced plans. Recent investments [...]...
  • Strong First Half From Hilton Food Group Hilton Food Group, the UK-based leading specialist international food packing business, has reported a 25.0% increase in turnover to £863.6 million and by 24.5% on a constant currency basis for the 28 weeks to 15 July 2018. Volumes increased by 12.7% reflecting growth in the UK, Ireland and Australia. Operating profit for the first half [...]...

Meiogenix, Lesaffre partner on yeast

June 07
11:13 2016

Bakers-YeastMeiogenix and Lesaffre have partnered up to develop improved industrial yeast strains using Meiogenix’s recombination technologies. The PhoeniX technology developed by Meiogenix controls the process of natural meiotic recombination and generates efficiently non–GM recombined yeast cells particularly for industrial strains where meiosis is impeded.

Meiogenix is a French biotech company that develops technologies to increase the genetic diversity of organisms by modulating meiosis and targeting recombination. Under the collaboration agreement Meiogenix will apply its non-GM technology to discover novel yeast strains with improved industrial properties that will be then industrialized by Lesaffre, a global key player in yeasts and fermentation.

“We are delighted of this collaboration with Lesaffre, a worldwide key player in the industrial yeast field. In the last few years we have carried out several R&D projects in yeast and we are glad to put into play the expertise and technologies we have developed,” said Giacomo Bastianelli, Co-founder & CEO of Meiogenix. “We believe that PhoeniX, a proprietary non-GM technology, can have a major impact in the yeast industry, especially for food applications where mainstream genetic engineering technologies are not yet an accepted option.”

The global market value for industrial yeast is projected to grow at a CAGR (compounded annual growth rate) of 8.8% and expected to reach $3.6B by 2018. The recent advances in genetic engineering techniques (e.g. CRISPR/CAS9, synthetic biology) can have an unprecedented impact in the development of novel yeast strains but severe concerns about genetically modified organisms used in the food and beverage industry are still a major hurdle for any development and commercialization. Therefore, research efforts will aim at developing new screening methods and technologies for the isolation of natural recombinants with the desired properties.

“Innovation has always been at the heart of Lesaffre’s development,” said Didier Colavizza, R&D Biotech Center Director at Lesaffre. “Research and Development is one of Lesaffre’s key drivers for success. Being the brainchild of Dr. Alain Nicolas, a scientist at the Institut Curie, Meiogenix’s innovative technology represents for us an opportunity to generate diversity in yeast. As an alternative to mutagenesis, this technique can improve yeasts and be applied in many fields from baking yeast to biofuels.”

Meiogenix, launched in 2011, is a biotech company developing breeding technologies to unlock the unexplored genetic diversity of organisms.

Lesaffre is a French yeast manufacturer, and the world’s largest producer. The company was founded by Louis Lesaffre, the co-founder of Bonduelle, in the mid-19th century.

About Author

admin

admin

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • September 25, 2018PPMA Show 2018
  • September 27, 2018Int'l Fruit Show (eurofruit)
  • September 30, 2018Trade Fair for Butchers, Caterers and Meat Industry (Meat Expo)
  • October 1, 2018Poznan International Fair
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber





Subscribe Here



Advertisements